Search
Now showing items 1-10 of 11
Article
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
| Date Issued:
2017 | Copyright:
open access
Article
Differential Shedding and Antibody Kinetics of Zika and Chikungunya Viruses, Brazil
| Date Issued:
2019 | Copyright:
open access
Article
Emergence of the East-Central-South-African genotype of Chikungunya virus in Brazil and the city of Rio de Janeiro may have occurred years before surveillance detection
| Date Issued:
2019 | Copyright:
open access
Article
An observational clinical case of Zika virus-associated neurological disease is associated with primary IgG response and enhanced TNF levels
| Date Issued:
2018 | Copyright:
restricted access
Article
Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae
| Date Issued:
2017 | Copyright:
open access
Article
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
| Date Issued:
2019 | Copyright:
open access
Article
Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo
| Date Issued:
2019 | Copyright:
open access
Article
2,8-bis (trifluoromethyl)quinoline analogs show improved anti-Zika virus activity, compared to mefloquine
| Date Issued:
2017 | Copyright:
restricted access
Article
N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity
| Date Issued:
2017 | Copyright:
open access
Article
Rapid antigen tests for dengue virus serotypes and Zika virus in patient serum
| Date Issued:
2017 | Copyright:
open access